4.5 Review

Central serous chorioretinopathy and glucocorticoids: an update on evidence for association

期刊

SURVEY OF OPHTHALMOLOGY
卷 63, 期 1, 页码 1-8

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.survophthal.2017.06.008

关键词

central serous chorioretinopathy; steroid; side effects; glucocorticoids; topical steroid; joint injections; pregnancy; transplantation

资金

  1. Research to Prevent Blindness, New York, NY

向作者/读者索取更多资源

Central serous chorioretinopathy is a common idiopathic retinal disease characterized by central vision loss from serous detachment of the neurosensory retina, serous pigment epithelial detachments, and leakage of fluid through the retinal pigment epithelium into the subretinal space. The concept of an association between exogenous glucocorticoid use and central serous chorioretinopathy is widely accepted among ophthalmologists. Here, we review the evidence for and against such an association. This evidence includes 2 large, case-control studies that found strong associations, and a smaller, population-based study that found no association. We conclude that the preponderance of the literature on this topic supports the existence of an association. Both exogenous and endogenous glucocorticoids have been implicated. Although a mechanism and a causal relationship remain to be established, the association deserves broader recognition among physicians who prescribe glucocorticoids. (C) 2017 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据